Stay updated on SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added as the latest update and Revision: v3.4.2 was removed. No changes to study content or data.
    Difference
    0.0%
    Check dated 2026-03-11T17:57:37.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed and the older government funding status notice (v3.4.1) has been removed. This is a minor administrative update that does not change study content, eligibility criteria, or results.
    Difference
    0.2%
    Check dated 2026-02-11T05:20:13.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a funding-status notice directing users to NIH/cc.gov and OPM status pages and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T05:11:44.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Adds a glossary display and updates QC-related labels and versioning (Revision: v3.4.0, Last Update Submitted that Met QC Criteria, No FEAR Act Data); removes older wording/labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-28T03:14:20.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T01:12:47.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The Study Locations were updated: new site listings across Brazil (Goiás, Rio Grande do Sul, São Paulo), China (Anhui, Beijing Municipality, Chongqing, Fujian, Guangdong, Guizhou, Heilongjiang, Hunan, Jiangsu, Jiangxi, Jilin, Liaoning, Ningxia, Shaanxi, Shandong, Shanghai Municipality, Shanxi, Tianjin Municipality, Yunnan), and South Africa (Gauteng, KwaZulu-Natal). The previous location sections were removed.
    Difference
    1%
    Check dated 2025-12-23T21:27:31.000Z thumbnail image

Stay in the know with updates to SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.